Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures

Journal of NeuroVirology

Volumn 13, Issue 2, 2007, Pages 160-167

  Robinson, Barry ^a   Li, Zhenzhong ^b   Nath, Avindra ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

AIDS; Antiretroviral; Dorsal root ganglia; HIV; Neuropathy; Nucleoside analogs

Indexed keywords

DIDANOSINE; GLYCOPROTEIN GP 120; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; ZALCITABINE; ZIDOVUDINE;

ARTICLE; AXONAL INJURY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG POTENCY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MICROTUBULE; NERVE CELL CULTURE; NERVE FIBER; NEUROTOXICITY; NONHUMAN; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORY NERVE CELL; SPINAL GANGLION; VIRUS PATHOGENESIS;

AXONS; CELLS, CULTURED; GANGLIA, SPINAL; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HUMANS; MICROSCOPY, ELECTRON; MICROTUBULES; MITOCHONDRIA; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34249092432     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701200102     Document Type: Article

References (31)

1. Berger, J. R. and Nath, A. (2000) Remedies for HIV-associated peripheral neuropathy. Neurology, 54, pp. 2037-2038.
2. Bruce-Keller, A. J., Chauhan, A., Dimayuga, F. O., Gee, J., Keller, J. N. and Nath, A. (2003) Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci, 23, pp. 8417-8422.
3. Coleman, M. (2005) Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci, 6, pp. 889-898.
4. Cossarizza, A TL and Mussini, C. (2002) Mitochondria and HIV infection: the first decade. J Biol Regulators Homeostatic Agents, 16, pp. 18-24.
5. Dalakas, M., Semino-Mora, C. and Leon-Monzon, M. (2001) Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC). Lab Invest, 81, pp. 1537-1544.
6. Dolin, R., Amato, D. A., Fischl, M. A., Pettinelli, C., Beltangady, M., Liou, S. H., Brown, M. J., Cross, A. P., Hirsch, M. S. and Hardy, W. D. (1995) Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. Arch Intern Med, 155, pp. 961-974.
7. Famularo, G MS, Marcellini, S., Trinchieri, V., Tzanfzoglou, S., Santini, G., Longo, A. and De Simone, C. (1997) Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS, 11, pp. 185-190.
8. Fischl, M., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D. and Schooley, R. T. (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med, 317, pp. 185-191.
9. Havlir, D., Tierney, C., Friedland, G. H., Pollard, R. B., Smeaton, L., Sommadossi, J. P., Fox, L., Kessler, H., Fife, K. H. and Richman, D. D. (2000) In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis, 182, pp. 321-325.
10. Hol, E., Sodaar, P. and Bar, P. R. (1994) Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspects. Ann N Y Acad Sci, 739, pp. 74-86.
11. Joseph, E., Chen, X., Khasar, S. G. and Levine, J. D. (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain, 107, pp. 147-158.
12. Katzenstein, D. A., Hammer, S. M., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., Merigan, T. C. and Hirsch, M. S. The AIDS Clinical Trials Group Study 175 Virology Study Team (1996). The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med, 335, pp. 1091-1098.
13. Keswani, S CCB, Hasan, C., Griffin, J. W., McArthur, J. C. and Hoke, A. (2003) FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann Neurol, 53, pp. 57-64.
14. Keswani, S. C., Leitz, G. J. and Hoke, A. (2004) Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett, 371, pp. 102-105.
15. Keswani, S CPC, Cherry, C. L., Hoke, A. and McArthur, J. C. (2002) HIV-associated sensory neuropathies. AIDS, 16, pp. 2105-2117.
16. Keswani, S CPM, Pardo, C. A., Griffin, J. W., McArthur, J. C. and Hoke, A. (2003) Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol, 54, pp. 287-296.
17. Nath, A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol, 71, pp. 2495-2499.
18. Masliah, E., Morey, M., DeTeresa, R., Terry, R. D. and Wiley, C. A. (1992) Cortical dendritic pathology in human deficiency virus encephalitis. Lab Invest, 66, pp. 285-291.
19. Mattson, M., Haughey, N. J. and Nath, A. (2005) Cell death in HIV dementia. Cell Death Differ, pp. 893-904.
20. McArthur, J. (2004) HIV dementia: An evolving disease. J Neuroimmunol, 157, pp. 3-10.
21. McArthur, J. C., Brew, B. J. and Nath, A. (2005) Neurological complications of HIV infection. Lancet Neurol, 4, pp. 543-555.
22. Melli, G., Keswani, S. C., Fischer, A., Chen, W. and Hoke, A. (2006) Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain, 129, pp. 1330-1338.
23. Moyle, G. (2005) Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. Antiviral Ther, 10, pp. M47-M52.
24. Nath, A., Conant, K., Chen, P., Scott, C. and Major, E. O. (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenonmenon. J Biol Chem, 274, pp. 17098-17102.
25. Nath, A., Hartloper, V., Furer, M. and Fowke, K. R. (1995) Infection of human fetal astrocytes with HIV-1: Viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol, 54, pp. 320-330.
26. Nosheny, R. L., Bachis, A., Acquas, E. and Mocchetti, I. (2004) Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: Potential implication for neuronal cell death. Eur J Neurosci, 20, pp. 2857-2864.
27. Pardo, C. A., McArthur, J. C. and Griffin, J. W. (2001) HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease. J Periph Nerv Syst, 6, pp. 21-27.
28. Popovic, M., Read-Connole, E. and Gallo, R. C. (1984) T4 positive hman neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet, 2, pp. 1472-1473.
29. Ratner, L., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rfalski, J. A., Whitehorn, E. A., Baumeister, K., Ivanoff, L., Petteway Jr, S. R., Pearson, M. L., Lautenberger, J. A., Papas, T. S., Ghrayab, J., Chang, N. T., Gallo, R. C. and Wong-Staal, F. (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, 313, pp. 277-283.
30. Skuta, G., Fischer, G. M., Janaky, T., Kele, Z., Szabo, P., Tozser, J. and Sumegi, B. (1999) Molecular mechanism of the short-term cardiotoxicity caused by dideoxycytidine (ddC): Modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem Pharmacol, 58, pp. 1915-1925.
31. Walker, U., Setzer, B. and Venhoff, N. (2002) Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS, 16, pp. 2165-2173.